Buffett InvestorsNZX
Back
CHI.NZ

Channel Infrastructure: From Oil Refinery to Biorefinery — And the Stock Has Nearly Doubled

NZ's Most Surprising Reinvention Story

Four years ago, Channel Infrastructure shut down New Zealand's only oil refinery at Marsden Point. It looked like a death sentence for the company. Instead, it turned out to be one of the smartest strategic pivots on the NZX.

Today, Channel Infrastructure operates the Marsden Point fuel import terminal — where refined fuel arrives by ship from Asia and gets pumped through a 170 km pipeline to Auckland. The company handles approximately 40% of New Zealand's total fuel supply, delivering over 3.5 billion litres annually. It's a simpler, higher-margin business than refining ever was, and the share price has responded accordingly.

Trading around $3.04 NZD, the stock has climbed from a 52-week low of $1.80 to near its 52-week high of $3.06 — a gain of roughly 69% over the past year.

FY2025: Cash Machine

The financial results tell the story of a business that's become remarkably efficient:

  • •Revenue: $137 million NZD
  • •EBITDA: $93.4 million, representing a 67% margin
  • •Normalised free cash flow: $66.9 million, up 5% with a 72% conversion rate
  • •Total dividend: 13.0 cents per share, up 18% on the prior year
  • •Dividend payout ratio: 80% of free cash flow

A 67% EBITDA margin is extraordinary. For context, most NZX-listed companies would be thrilled with 20-30%. Channel Infrastructure achieves this because the import terminal business is inherently capital-light once built — fuel comes in by ship, gets stored in tanks, and flows through the pipeline. There's not a lot of variable cost.

The 18% dividend increase signals management's confidence in the sustainability of these cash flows. At the current share price, the trailing yield sits around 4.3%.

The Biorefinery Opportunity

Here's where it gets really interesting. Channel Infrastructure is progressing a biorefinery project at Marsden Point that could produce sustainable aviation fuel (SAF) — and the consortium backing it is seriously impressive:

  • •Air New Zealand and Qantas as offtake partners (they'll buy the fuel)
  • •Renova (biofuel technology)
  • •ANZ Bank (financing)
  • •Kent (engineering)

Final form agreements for feedstock supply and product offtake have been prepared, and a final investment decision is expected in 2026. If it goes ahead, this would make Marsden Point one of the first SAF production facilities in the Southern Hemisphere.

The aviation industry is under enormous pressure to decarbonise, and airlines globally need SAF supply to meet regulatory targets. NZ-produced SAF would be a strategic asset, particularly for Air New Zealand's long-haul fleet.

Key Metrics

  • •Share price: ~$3.04 NZD
  • •Market cap: ~$1.26 billion NZD
  • •52-week range: $1.80 – $3.06
  • •EBITDA margin: 67%
  • •Dividend: 13.0 cents per share (yield ~4.3%)
  • •Forward EPS consensus: $0.06 NZD
  • •Analyst consensus target: $2.78 NZD

Interestingly, the analyst consensus target of $2.78 is actually below the current share price. This suggests the market has run ahead of analyst expectations, likely pricing in biorefinery upside that conservative analyst models haven't fully captured yet.

What to Watch

  • •Biorefinery final investment decision: This is the single biggest catalyst for the stock. A positive decision would validate the growth story and could drive a significant re-rating. A negative decision or delay would remove the key bull thesis.
  • •Pipeline throughput volumes: Channel's revenue is directly tied to how much fuel flows through its infrastructure. Any structural decline in NZ fuel demand (from EV adoption, for example) would be a headwind.
  • •Dividend growth: Management has been steadily increasing the payout. Continued dividend growth would support the share price even if the biorefinery takes longer than expected.
  • •EV adoption rates: NZ's transition to electric vehicles will gradually reduce petrol and diesel demand. This is a long-term structural risk for the core business, which makes the biorefinery pivot strategically important.

The Bottom Line

Channel Infrastructure is a rare thing on the NZX: a company that successfully reinvented itself. The import terminal business generates fat margins and growing dividends, while the biorefinery project offers genuine growth optionality. At $3.04, the stock is priced for the current cash flows plus some biorefinery optimism. If the biorefinery gets the green light, there's likely more upside. If it doesn't, the core terminal business still generates attractive, predictable returns. The main risk is that you're buying near 52-week highs with analysts actually targeting lower — so patience on entry might be rewarded.

*Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice. Stock data may not be real-time. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.*